Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain

References

• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646–56
   PubMed Web of Science ®Google Scholar
• Guo HR, Tanaka S, Cameron LL, et al. Back pain among workers in the United States: national estimates and workers at high risk. Am J Ind Med 1995;28:591–602
   PubMed Web of Science ®Google Scholar
• Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 2004;29:79–86
   Google Scholar
• Rizzo JA, Abbott TA, III, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care 1998;36:1471–88
   PubMed Web of Science ®Google Scholar
• Lidbeck J. Central hyperexcitability in chronic musculoskeletal pain: a conceptual breakthrough with multiple clinical implications. Pain Res Manag 2002;7:81–92
   PubMedGoogle Scholar
• Moskowitz MH. Pharmacotherapy of neuropathic low back pain. Curr Pain Headache Rep 2003;7:178–87
   PubMedGoogle Scholar
• Deyo RA. Drug therapy for back pain: which drugs help which patients? Spine 1996;21:2840–50
   PubMed Web of Science ®Google Scholar
• Garofalo JP, Polatin P. Low back pain: an epidemic in industrialized countries. In: Gatchel RJ, Turk DC, editors. Psychosocial factors in pain. New York (NY): Guilford Press; 1999
   Google Scholar
• Sorensen J, Kalman S, Tropp H, Bengtsson M. Can a pharmacological pain analysis be used in the assessment of chronic low back pain? Eur Spine J 1996;5:236–42
   PubMedGoogle Scholar
• Masubuchi Y, Saito H, Horie T. Structural requirements for the hepatotoxicity of nonsteroidal anti-inflammatory drugs in isolated rat hepatocytes. J Pharmacol Exp Ther 1998;287:208–13
   Google Scholar
• Perazella MA, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med 2001;111:64–7
   PubMed Web of Science ®Google Scholar
• Weinblatt ME. Drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs). Scand J Rheumatol Suppl 1989;83:7–10
   PubMedGoogle Scholar
• Ehrlich GE. Low back pain. Bull World Health Organ 2003;81:671–6
   PubMed Web of Science ®Google Scholar
• Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves post-herpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533–8
   PubMed Web of Science ®Google Scholar
• Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 2002;18: 297–301
   Google Scholar
• Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39–44
   PubMed Web of Science ®Google Scholar
• Comer AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59:245–9
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236–40
   PubMed Web of Science ®Google Scholar
• White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med 2003;4:321–30
   PubMed Web of Science ®Google Scholar
• Burch F, Codding C, Patel N, Sheldon E. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial. Osteoarthritis Cartilage 2004;12:253–5
   PubMed Web of Science ®Google Scholar
• Argoff CE. New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000;16:S62–S66
   PubMed Web of Science ®Google Scholar
• Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000;16:205–8
   PubMed Web of Science ®Google Scholar
• Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332–8
   PubMed Web of Science ®Google Scholar
• Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106:151–8
   PubMed Web of Science ®Google Scholar
• Palmer KT, Walsh K, Bendall H, Cooper C, Coggon D. Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. Br Med J 2000;320: 1577–8
   Google Scholar
• Pruitt SD, Von Korff M. Improving the management of low back pain: a paradigm shift for primary care. In: Turk DC, Gatchel RJ, editors. Psychosocial approaches to pain management: a practitioner’s handbook. New York (NY): Guilford Press; 2002
   Google Scholar
• Chung K, Lee BH, Yoon YW, Chung JM. Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model. J Comp Neurol 1996;376:241–52
   PubMed Web of Science ®Google Scholar
• McLachlan EM, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993;363:543–6
   PubMed Web of Science ®Google Scholar
• Fields HL, Rowbotham MC. Multiple mechanisms of neuropathic pain: a clinical perspective. In: Gebhart GF, Hammond DL, et al., editors. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press; 1994. p. 437–54
   Google Scholar
• Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38:333–8
   Google Scholar
• Laird JM, Carter AJ, Grauert M, Cervero F. Analgesic activity of a novel use-dependent sodium channel blocker, crobenetine, in mono-arthritic rats. Br J Pharmacol 2001;134: 1742–8
   PubMed Web of Science ®Google Scholar
• Zhang JM, Li H, Munir MA. Decreasing sympathetic sprouting in pathologic sensory ganglia: a new mechanism for treating neuropathic pain using lidocaine. Pain 2004;109:143–9
   Google Scholar